Company Search:
Advanced Search
Sponsored Links
Cellectis SA Company Snapshot
Cellectis SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellectis SA with three other companies in this sector in France: Innate Pharma S.A. (2015 sales of 17.91 million Euro [US$19.66 million] of which 100% was Licensing Revenue), Eurofins-Cerep SA (22.51 million Euro [US$24.71 million] ), and Adocia SAS (36.94 million Euro [US$40.54 million] of which 100% was Regenerative Medicine).

Sales Analysis. Sales increased substantially in 2015: Cellectis SA reported sales of 56.39 million Euro (US$61.89 million) for the year ending December of 2015. This represents an increase of 160.7% versus 2014, when the company's sales were 21.63 million Euro. Sales of Therapeutics saw an increase of 151.3% in 2015, from 22.74 million Euro to 57.14 million Euro. Not all segments of Cellectis SA experienced an increase in sales in 2015: sales of Plants fell 96.2% to 44,000.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cellectis SA
  Stock Performance Chart for Cellectis SA
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 18.51
(Figures in Euro)
1 Week -8.7%   13 Weeks -17.4%  
4 Weeks -21.1%   52 Weeks -18.6%  
Cellectis SA Key Data:
  Ticker: ALCLS Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 56,385,000
(Year Ending Jan 2016).
Employees: 89
  Currency: Euro Market Cap: 650,067,998
  Fiscal Yr Ends: December Shares Outstanding: 35,119,827
  Share Type: Action Ordinaires Closely Held Shares: 8,128,763
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.